{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:39:12Z","timestamp":1774618752562,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.arcped.2007.09.013","type":"journal-article","created":{"date-parts":[[2008,1,3]],"date-time":"2008-01-03T15:37:03Z","timestamp":1199374623000},"page":"24-28","source":"Crossref","is-referenced-by-count":11,"title":["L\u2019utilisation de l\u2019hydroxyur\u00e9e dans les formes s\u00e9v\u00e8res de la dr\u00e9panocytose\u00a0: \u00e9tude de 47 cas p\u00e9diatriques tunisiens"],"prefix":"10.1016","volume":"15","author":[{"given":"F.","family":"Mellouli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bejaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2007.09.013_bib1","first-page":"7","article-title":"Current therapy of sickle cell disease","volume":"90","author":"Aliyu","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.arcped.2007.09.013_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2141.2003.04143.x","article-title":"Therapeutic challenges in childhood sickle cell disease part 1: current and future treatment options","volume":"120","author":"Armolia","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcped.2007.09.013_bib3","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood.V88.6.1960.bloodjournal8861960","article-title":"Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial","volume":"88","author":"Ferster","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2007.09.013_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2141.2003.04144.x","article-title":"Therapeutic challenges in childhood sickle cell disease part 2: a problem oriented approach","volume":"120","author":"Armolia","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcped.2007.09.013_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00043426-199801000-00004","article-title":"Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy","volume":"20","author":"Olivieri","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.arcped.2007.09.013_bib6","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2004-12-4973","article-title":"Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extention study","volume":"106","author":"Hankins","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2007.09.013_bib7","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1001\/jama.289.13.1692","article-title":"Hydroxyurea and sickle cell disease: a chance for every patient","volume":"289","author":"Weiner","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.arcped.2007.09.013_bib8","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.arcped.2007.09.013_bib9","first-page":"1692","article-title":"The effect of hydroxyurea on vasculopathy in a child with sickle cell disease","volume":"23","author":"Helton","year":"2002","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.arcped.2007.09.013_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.10205","article-title":"Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA)","volume":"71","author":"Sumoza","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.arcped.2007.09.013_bib11","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V94.9.3022","article-title":"Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sicle cell disease","volume":"94","author":"Ware","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2007.09.013_bib12","first-page":"125","article-title":"Long-term hydroxyurea treatment in children with sickle cell disease: Tolerance and clinical outcomes","volume":"91","author":"De Montalembert","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.arcped.2007.09.013_bib13","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood-2004-07-2704","article-title":"Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: The Belgian experience","volume":"105","author":"Gulbis","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2007.09.013_bib14","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS Study, a Phase I\/II Trial","volume":"94","author":"Kinney","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2007.09.013_bib15","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood.V97.11.3628","article-title":"Five years of experience with hydroxyurea in children and young adults with sickle cell disease","volume":"97","author":"Ferster","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2007.09.013_bib16","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V98.9.2878","article-title":"Is hydroxyurea leukemogenic in children with sickle cell disease?","volume":"98","author":"De Montalembert","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2007.09.013_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/adc.81.5.437","article-title":"Preliminary report of a toxicity study of hydroxyurea in sickle cell disease","volume":"81","author":"De Montalembert","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.arcped.2007.09.013_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1081\/HEM-100103065","volume":"25","author":"Rigano","year":"2001","journal-title":"Hemoglobin"},{"key":"10.1016\/j.arcped.2007.09.013_bib19","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood-2003-07-2475","article-title":"Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease","volume":"103","author":"Zimmerman","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.arcped.2007.09.013_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0268-960X(02)00074-7","article-title":"The role of hydroxyurea in the management of sickle cell disease","volume":"17","author":"Davies","year":"2003","journal-title":"Blood Rev"},{"key":"10.1016\/j.arcped.2007.09.013_bib21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2007.09.013_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1067\/mpd.2001.120093","article-title":"Hydroxyurea in very young children with sickle cell anemia is not a cure-all","volume":"139","author":"Powers","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2007.09.013_bib23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1067\/mpd.2001.119590","article-title":"A two-years pilot trial of hydroxyurea in very young children with sickle cell anemia","volume":"139","author":"Wang","year":"2001","journal-title":"J Pediatr"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X07005921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X07005921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T09:13:21Z","timestamp":1588238001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X07005921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0929693X07005921"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2007.09.013","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}